We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GD:NYSEGeneral Dynamics Corporation Analysis

Data as of 2026-09-07 - not real-time

$359.39

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

General Dynamics Corporation is priced at $359.39 and its moving averages line up in bullish order, the shorter sitting above the longer. Across the trailing 30 sessions it lost 7.1%. Relative strength is 31.0 — approaching oversold — and the MACD signal is bearish. The recent range runs from support at $358.04 up to resistance at $397.20.
On valuation the read is fair — earnings multiple of 21.9 versus a 28.5 sector average, below the peer group. Consensus targets land 16.9% above where the shares trade now. Revenue is growing at 8.1% on a 8.2% profit margin. The 1.77% dividend yield looks covered by current payout levels.
Risk comes out at 3 of a possible 10, a low reading. With 30-day volatility of 18.0%, a beta of 0.44 and a maximum drawdown of 15.2%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to buy, carrying 6/10 conviction.

Top Market Events

General Dynamics NYSE:GD unit GDIT has been awarded a US$1.General Dynamics stock is trading above $380 after Q2 2026 earnings topped expectations and revenueGeneral Dynamics NYSE:GD filed a significant shelf registration for a major common stock offering tied to its Employee...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 354.53
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 21.9 versus sector average of 28.5
  • Trading above the 200-day average of 354.53

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 21.9 versus sector average of 28.5
  • Analyst targets imply +16.9% versus the current price
  • Return on equity of 17.8%

Key Metrics & Analysis

Financial Health

Revenue Growth8.10%
Profit Margin8.18%
P/E Ratio21.9
ROE17.80%
ROA6.08%
Debt/Equity35.34
P/B Ratio3.6
Op. Cash Flow$7.7B
Free Cash Flow$4.4B
Industry P/E28.5

Technical Analysis

TrendBullish
RSI31.0
Support$358.04
Resistance$397.20
MA 20$382.50
MA 50$377.93
MA 200$354.53
MACDBearish
VolumeIncreasing
Fear & Greed Index94.11

Valuation

Fair Value$271.04
Target Price$420.02
Upside/Downside16.87%
GradeFair
TypeBlend
Dividend Yield1.77%

Risk Assessment

Beta0.44
Volatility17.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.